Collection of telemedical data from patients with chronic heart failure for a post-hoc analysis of an AI approach to vital signs processing (short title: Telemed5000-HF) - Telemed5000-HF

Charité- Campus Charité Mitte0 sites100 target enrollmentMay 3, 2023

Overview

No summary available.

Registry

who.int

Start Date

May 3, 2023

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Charité- Campus Charité Mitte

•1\. patients with chronic heart failure in NYHA class II or III.
•2\. echocardiographically determined left ventricular ejection fraction (LVEF) \=45% or LVEF \>45% \+ at least 1 diuretic in long\-term medical therapy.
•3\. have been hospitalised for cardiac decompensation\<12 months prior to inclusion in the study (not related to a proven myocardial infarction without pre\-existing moderately restricted LVEF) (doctor's letter available).
•4\. no moderate or severe depression
•5\. written informed consent of the patient

•1\. hospitalisation within the last 7 days before study start (exept due to cardiac decompensation)
•2\. condition after implantation of a mechanical cardiac assist system
•3\. acute coronary syndrome within the last 7 days before study inclusion
•4\. high urgent HTX listing
•5\. planned revascularisation, TAVI, mitraclip and/or CRT implantation within 3 months of study inclusion
•6\. revascularisation and/or CRT implantation within 3 months prior to study inclusion
•7\. chronic drug or alcohol abuse as assessed by the physician
•8\. terminal renal failure with haemodialysis treatment
•9\. inability or unwillingness to perform telemonitoring (e.g. dementia, blindness, deafness, wheelchair use, insufficient knowledge of German, speech or voice disorders affecting voice analysis, limited informal self\-determination)
•10\. illnesses with a life expectancy\<12 months